SCHEMBL3461677

SCHEMBL3461677

[CH2]N(C)Cc1cnccn1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
POLB P06746 1/20 0.39
GBA1 P04062 1/20 0.39
HRH1 P35367 6/20 0.36
CYP2D6 P10635 5/20 0.36
GAA P10253 1/20 0.35
KCNH2 Q12809 2/20 0.35
CHRM1 P11229 1/20 0.35
HTR2A P28223 1/20 0.35
TDP1 Q9NUW8 1/20 0.34
CHRNB2 P17787 2/20 0.34
CHRNA4 P43681 2/20 0.34
HSP90AA1 P07900 1/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
HDAC1 Q13547 2/20 0.33
HDAC3 O15379 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3461681 0.83 CHRNB2 (0.45) CYP3A4CYP1A2CYP2C9CYP2C19POLB
SCHEMBL20882979 0.83 GAA (0.45) CYP3A4CYP1A2CYP2C9CYP2C19POLB
SCHEMBL16741951 0.78 CYP1A2 (0.47) CYP3A4CYP1A2CYP2C9CYP2C19POLB
SCHEMBL12089147 0.76 CYP3A4 (0.41) CYP3A4CYP1A2CYP2C9CYP2C19POLB
SCHEMBL14067071 0.76 POLB (0.44) CYP3A4CYP1A2CYP2C9CYP2C19POLB
SCHEMBL5772725 0.75 CYP1A2 (0.40) CYP3A4CYP1A2CYP2C9CYP2C19POLB
Trimethylammonium SCHEMBL27628866 0.74 POLB (0.41) CYP3A4CYP1A2CYP2C9CYP2C19POLB
SCHEMBL3320948 0.74 TDP1 (0.52) CYP3A4CYP1A2CYP2C9CYP2C19POLB
SCHEMBL12087486 0.73 HRH1 (0.43) CYP3A4CYP1A2CYP2C9CYP2C19POLB
SCHEMBL19210477 0.73 TDP1 (0.44) CYP3A4CYP1A2CYP2C9CYP2C19POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8580812-B2 Heteroaryl amide analogues as P2X7 antagonists H. LUNDBECK A/S (DK) 2013-11-12 US disclosed
US-20100266509-A1 HETEROARYL AMIDE ANALOGUES AS P2X7 ANTAGONISTS H. Lindbeck A/S (DK) 2010-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100266509-A1 HETEROARYL AMIDE ANALOGUES AS P2X7 ANTAGONISTS P2RX7, P2RX3, P2RX2 CYP3A4 1354/4885CYP1A2 837/4885CYP2C9 780/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.